Chemed (CHE)
(Delayed Data from NYSE)
$582.06 USD
-3.21 (-0.55%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $582.47 +0.41 (0.07%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
Income Statements
Fiscal Year end for Chemed Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,264 | 2,135 | 2,139 | 2,080 | 1,939 |
Cost Of Goods | 1,466 | 1,370 | 1,369 | 1,378 | 1,321 |
Gross Profit | 799 | 765 | 770 | 701 | 617 |
Selling & Adminstrative & Depr. & Amort Expenses | 458 | 422 | 427 | 312 | 360 |
Income After Depreciation & Amortization | 341 | 344 | 343 | 390 | 257 |
Non-Operating Income | 13 | -9 | 9 | 9 | 9 |
Interest Expense | 3 | 5 | 2 | 2 | 5 |
Pretax Income | 350 | 330 | 350 | 396 | 262 |
Income Taxes | 78 | 80 | 82 | 77 | 42 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 273 | 250 | 269 | 319 | 220 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 273 | 250 | 269 | 319 | 220 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 402 | 403 | 402 | 447 | 303 |
Depreciation & Amortization (Cash Flow) | 61 | 60 | 59 | 57 | 46 |
Income After Depreciation & Amortization | 341 | 344 | 343 | 390 | 257 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 15.20 | 15.10 | 15.94 | 16.40 | 16.53 |
Diluted EPS Before Non-Recurring Items | 20.30 | 19.75 | 19.33 | 18.08 | 13.95 |
Diluted Net EPS (GAAP) | 17.93 | 16.53 | 16.85 | 19.48 | 13.31 |
Fiscal Year end for Chemed Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 595.88 | 589.23 | 585.91 | 564.53 | 553.82 |
Cost Of Goods | 389.75 | 385.13 | 358.35 | 362.36 | 374.19 |
Gross Profit | 206.13 | 204.11 | 227.57 | 202.17 | 179.62 |
SG&A, R&D, and Dept/Amort Expenses | 118.00 | 131.78 | 116.17 | 115.33 | 110.12 |
Income After SG&A, R&D, and Dept/Amort Expenses | 88.13 | 72.33 | 111.40 | 86.84 | 69.50 |
Non-Operating Income | 6.13 | 12.58 | 4.54 | 6.86 | 1.61 |
Interest Expense | 0.43 | 0.43 | 0.34 | 0.44 | 0.77 |
Pretax Income | 93.83 | 84.49 | 115.59 | 93.27 | 70.34 |
Income Taxes | 22.94 | 19.47 | 25.54 | 18.31 | 16.97 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 70.89 | 65.02 | 90.05 | 74.96 | 53.38 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 70.89 | 65.02 | 90.05 | 74.96 | 53.38 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 15.25 | 15.34 | 15.27 | 15.20 | 15.22 |
Diluted EPS Before Non-Recurring Items | 5.01 | 4.68 | 6.60 | 5.32 | 4.71 |
Diluted Net EPS (GAAP) | 4.65 | 4.24 | 5.91 | 4.93 | 3.51 |